WHO criteria in tumor response

The WHO criteria have been developed in the 1980s to standardized reporting of cancers in clinical trial.​ These criteria Nowadays, newer criteria often based on the WHO criteria (such as RECIST, mRECIST, Choi criteria, Lugano response criteria), have widely replaced the WHO criteria in clinical practice 1.

  • no lesions detected for ≥ 4 weeks 

  • ≥ 50% decrease in sum of the products of diameters
    • confirmed at ≥ 4 weeks
  • ≥25% increase in products of diameters in one or more lesions
  • new lesions
  • none of the above
Share article

Article information

rID: 57912
System: Oncology
Section: Staging
Synonyms or Alternate Spellings:

Support Radiopaedia and see fewer ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.